Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Annals of Surgical Oncology

• Publication date

  2009-04-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1245/s10434-009-0408-6PMID 19396496
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography

  2008cited by this paper
• Role of endoscopic ultrasound in diagnosis and therapy of pancreatic adenocarcinoma.

  2007cited by this paper
• Pancreatic adenocarcinoma: value of multidetector CT angiography in preoperative evaluation.

  2007cited by this paper
• Diagnosis by endoscopic ultrasound guided fine needle aspiration of tuberculous lymphadenitis involving the peripancreatic lymph nodes: a case report.

  2007cited by this paper
• EUS-guided fine needle injection (FNI) and anti-tumor therapy

  2006cited by this paper
• PET/CT impacts on the management of patients with resectable cancer of the pancreas

  2006cited by this paper
• Early specialist repair of biliary injury

  2006cited by this paper
• Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy

  2006cited by this paper
• Frequency of major complications after EUS-guided FNA of solid pancreatic masses: a prospective evaluation.

  2006cited by this paper
• The current role of staging laparoscopy for adenocarcinoma of the pancreas: a review.

  2006cited by this paper
• Evaluation of bowel distention and bowel wall appearance by using neutral oral contrast agent for multi-detector row CT.

  2006cited by this paper
• State of the art lecture: Endoscopic ultrasound (EUS) and FNA in pancreatico-biliary tumors

  2006cited by this paper
• The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma

  2006cited by this paper
• Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness.

  2006cited by this paper
• The Clinical Usefulness of 18-Fluorodeoxyglucose Positron Emission Tomography in the Differential Diagnosis, Staging, and Response Evaluation After Concurrent Chemoradiotherapy for Pancreatic Cancer

  2006cited by this paper
• CA 19-9 levels predict results of staging laparoscopy in pancreatic cancer

  2005cited by this paper
• Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by Computed Tomography

  2005cited by this paper
• A first report of tumor seeding because of EUS-guided FNA of a pancreatic adenocarcinoma.

  2005cited by this paper
• Positron Emission Tomography/Computed Tomography Influences on the Management of Resectable Pancreatic Cancer and Its Cost-Effectiveness

  2005cited by this paper
• Detection of small pancreatic tumors with multiphasic helical CT.

  2004cited by this paper
• A Cost-Minimization Analysis of Alternative Strategies in Diagnosing Pancreatic Cancer

  2004cited by this paper
• Predicting resectability of periampullary cancer with three-dimensional computed tomography

  2004cited by this paper
• Endoscopic ultrasound‐guided fine‐needle aspiration biopsy: A powerful tool to obtain samples from small lesions

  2004cited by this paper
• Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA.

  2003influential reference
• Utility of Staging Laparoscopy in Subsets of Peripancreatic and Biliary Malignancies

  2002cited by this paper
• Magnetic resonance imaging of the pancreas in 2001

  2002cited by this paper
• Adenocarcinoma of the pancreas: CT imaging.

  2002cited by this paper
• Magnetic resonance imaging of the pancreas in 2001

  2002cited by this paper
• Laparoscopy in the staging of pancreatic cancer

  2001cited by this paper
• Multi--detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma.

  2001cited by this paper
• Impact of laparoscopic staging in the treatment of pancreatic cancer.

  2000cited by this paper
• Impact of endoscopic ultrasound on the management and outcome of pancreatic carcinoma

  2000cited by this paper
• A critical appraisal of laparoscopic staging in hepatobiliary and pancreatic malignancy.

  2000cited by this paper
• Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT.

  1997cited by this paper
• The role of laparoscopy in the management of suspected pancreatic and periampullary malignancies

  1997cited by this paper
• The use of helical CT and CT angiography to predict vascular involvement from pancreatic cancer: correlation with findings at surgery.

  1997cited by this paper
• EndoScope: world literature reviews

  1996cited by this paper
• Magnetic Resonance Imaging of the Pancreas

  1988cited by this paper
• Magnetic resonance imaging of the pancreas.

  1984cited by this paper

• Society of surgical oncology medical student & trainee primer for hepatopancreatobiliary surgical oncology

  2026cites this paper
• Validation of 3 high-risk resectable hepatocellular carcinoma models

  2026cites this paper
• Redefining Upfront Resectable Pancreatic Ductal Adenocarcinoma: Should Vein Abutment Matter?

  2026cites this paper
• Surgical and survival outcomes of neoadjuvant IMRT-based chemoradiotherapy versus upfront surgery in borderline resectable pancreatic cancer: a retrospective cohort study.

  2026cites this paper
• Systemic immunomodulation by irreversible electroporation versus stereotactic ablative body radiotherapy in locally advanced pancreatic cancer: the CROSSFIRE trial

  2025cites this paper
• Exploring the survival benefits of surgical treatment for pancreatic adenocarcinoma using the DeepSurv neural network model

  2025cites this paper
• Advances in the Management of Pancreatic Cancer: Current Strategies and Emerging Therapies

  2025cites this paper
• Patterns of treatment and survival in borderline resectable and locally advanced pancreatic cancer.

  2025cites this paper
• Therapie des Pankreaskarzinoms: Innovative Chirurgie und moderne Systemtherapien

  2025cites this paper
• Evaluating the preoperative accuracy of multislice ct in determining resectability of periampullary pancreatic carcinoma

  2025cites this paper
• Impact of Surgical Resection After Induction Gemcitabine Plus S-1-Based Chemoradiotherapy in Patients with Locally Advanced Pancreatic Ductal Adenocarcinoma: A Focus on UR-LA Cases

  2025cites this paper
• Single-Fraction SBRT for Locally Advanced Pancreatic Cancer Using Total Intravenous Anaesthesia and Optical Surface Guidance: Technique and Preliminary Results

  2025cites this paper
• Comparison of efficacy and safety between neoadjuvant therapy and surgical treatment for resectable pancreatic cancer: A systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer

  2025cites this paper
• Evaluation of Recurrence Risk in Irreversible Electroporation-Treated Pancreatic Adenocarcinoma Patients Using Radiomics Signatures

  2025cites this paper
• Survival Outcomes in Nonmetastatic pT4 Pancreatic Ductal Adenocarcinoma: A SEER Database Analysis Comparing Neoadjuvant Therapy and Upfront Surgery with Propensity Score Matching

  2025cites this paper
• Periarterial divestment for borderline and locally advanced pancreatic cancer: An analysis of 125 cases in a single center.

  2025cites this paper
• Indian Consensus Guidelines for the Management of Pancreatic Cancer

  2025cites this paper
• Hypertension and tachycardia induced by irreversible electroporation in pancreatic cancer: An analysis based on clinical data

  2025cites this paper
• Predicting prognosis and optimal timing for surgery using CA 19-9 in patients with pancreatic cancer who underwent FOLFIRINOX-based neoadjuvant therapy: a retrospective single-center cohort study

  2025cites this paper
• Responsive nanomedicine strategies achieve pancreatic cancer precise theranostics

  2025cites this paper
• Testing remote feedback using a virtual semi-automated educational tool for the detection of pancreatic tumour-vessel contact on staging CT.

  2025cites this paper
• Surgery and neoadjuvant therapy in locally advanced pancreatic cancer: an umbrella review of survival, resection outcomes, and cost-effectiveness

  2025cites this paper
• The role of lymphocyte-to-monocyte ratio as a prognostic index to predict poor prognosis in patients with unresectable pancreatic cancer treated with chemotherapy

  2025cites this paper
• Efficacy of irreversible electroporation combined with immunotherapy versus irreversible electroporation alone in locally advanced pancreatic cancer: a propensity score-matched retrospective study

  2025cites this paper
• A logistic regression model to predict long-term survival for borderline resectable pancreatic cancer patients with upfront surgery

  2025cites this paper
• Hypofractionated radiotherapy for pancreatic cancer: What role in 2025?

  2025cites this paper
• Imaging of pancreatic ductal adenocarcinoma: a narrative review

  2025cites this paper
• Key preoperative findings for predicting vascular invasion and recurrence after conversion surgery after chemotherapy in pancreatic cancer

  2025cites this paper
• Dose-Escalated SBRT for Borderline and Locally Advanced Pancreatic Cancer: Resectability Rate and Pathological Results of a Multicenter Prospective Study

  2025cites this paper
• Neoadjuvant treatment versus upfront surgery in borderline resectable and resectable pancreatic ductal adenocarcinoma: meta-analysis

  2025cites this paper
• HIFU induces reprogramming of the tumor immune microenvironment in a pancreatic cancer mouse model

  2025cites this paper
• A Novel Deep Learning–based Pathomics Score for Prognostic Stratification in Pancreatic Ductal Adenocarcinoma

  2025cites this paper
• Comparative study between venous and standard resections for pancreatic head carcinoma

  2025cites this paper
• Intraoperative strategies and techniques to achieve surgical radicality in pancreatic cancer

  2024cites this paper
• Surgery for Borderline Resectable Pancreatic Ductal Adenocarcinoma: Preoperative Planning, Technical Considerations, and Building a Program.

  2024cites this paper
• Clinical Outcomes of Surgery after Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Ductal Adenocarcinoma

  2024cites this paper
• Development and Validation of a Survival Prediction Model for Patients With Pancreatic Cancer

  2024cites this paper
• The Evolving Role of Neoadjuvant Radiation Therapy in Pancreatic Adenocarcinoma

  2024cites this paper
• Risk factors for the development of pancreatic fistula after pancreaticoduodenectomy

  2024cites this paper
• Modern Treatment Strategies for Borderline Resectable Pancreatic Cancer.

  2024cites this paper
• Prognostic implication of extra-pancreatic organ invasion in resectable pancreas ductal adenocarcinoma in the pancreas tail.

  2024cites this paper
• Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments

  2024cites this paper
• Use of Vascular Shunt at the Time of Pancreatectomy with Venous Resection: A Systematic Review

  2024cites this paper
• An update on pancreatic cancer imaging, staging, and use of the PACT-UK radiology template pre- and post-neoadjuvant treatment

  2024cites this paper
• Chemotherapy and radiotherapy for advanced pancreatic cancer.

  2024cites this paper
• Do pre-operative endoscopic procedures, impact the surgical outcomes of robotic pancreaticoduodenectomy?

  2024cites this paper
• Inter-reader agreement of pancreatic adenocarcinoma resectability assessment with photon counting versus energy integrating detector CT

  2024cites this paper
• The Difficulty of Detecting Occult Metastases in Patients with Potentially Resectable Pancreatic Cancer: Development and External Validation of a Preoperative Prediction Model

  2024cites this paper
• Combination of modified FOLFIRINOX with stereotactic body radiotherapy as an induction therapy for locally advanced pancreatic adenocarcinoma – a prospective single-arm study

  2024cites this paper
• The Oncological Stress Test of Neoadjuvant Therapy: A Systematic Review in Outcomes of Neoadjuvant Therapy Compared to Upfront Resection Approach for Borderline Resectable Pancreatic Adenocarcinoma

  2024cites this paper
• Therapie des Pankreaskarzinoms: Innovative Chirurgie und moderne Systemtherapien

  2024cites this paper
• Stereotactic body radiotherapy for pancreatic cancer – A systematic review of prospective data

  2024cites this paper
• Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and Challenges

  2024cites this paper
• Role of Multidetector CT in Preoperative Evaluation of Periampullary Neoplasms

  2024cites this paper
• A meta-analysis on the efficacy of endoscopic ultrasonography for treatment of pancreatic cancer

  2024cites this paper
• Use of Diagnostic Laparoscopy and Peritoneal Washings for Pancreatic Cancer.

  2024cites this paper
• Radiochemotherapy in Pancreatic Cancer

  2024cites this paper
• Advances in Surgery and (Neo) Adjuvant Therapy in the Management of Pancreatic Cancer.

  2024cites this paper
• New Frontiers in Pancreatic Cancer Management: Current Treatment Options and the Emerging Role of Neoadjuvant Therapy

  2024cites this paper
• Anatomical and Biological Considerations to Determine Resectability in Pancreatic Cancer

  2024cites this paper
• Hong Kong consensus recommendations on the management of pancreatic ductal adenocarcinoma.

  2024cites this paper
• Validation of a Resectability Scoring System for Prediction of Pancreatic Adenocarcinoma Surgical Outcomes

  2023cites this paper
• Immune checkpoint inhibitors for advanced pancreatic cancer

  2023cites this paper
• Prognosis of Pancreatic Cancer Based on Resectability: A Single Center Experience

  2023cites this paper
• Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on RECIST guidelines: is MRI as effective as CT?

  2023cites this paper
• Validation of the Anatomical and Biological Definitions of Borderline Resectable Pancreatic Cancer According to the 2017 International Consensus for Survival and Recurrence in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Upfront Surgery

  2023cites this paper
• Technical options in surgery for artery-involving pancreatic cancer: Invasion depth matters

  2023cites this paper
• Neoadjuvant therapy for pancreatic cancer

  2023cites this paper
• Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma

  2023cites this paper
• Advances in the management of pancreatic cancer

  2023cites this paper
• Surgical management of pancreatic ductal adenocarcinoma: a narrative review

  2023cites this paper
• Pancreatic ductal adenocarcinoma staging: a narrative review of radiologic techniques and advances

  2023cites this paper
• A Visual Aid Tool for Detection of Pancreatic Tumour-Vessel Contact on Staging CT: A Retrospective Cohort Study

  2023cites this paper
• Improvement of methods of diagnosis and treatment of patients with obstructive jaundice of tumor genesis

  2023cites this paper
• Neoadjuvant Chemotherapy or Combined Chemo-Radiation Therapy of Pancreatic Ductal Adenocarcinoma Differentially Shift Immune Activation, ECM Composition, Energy Metabolism, and Ribosomal Proteins of the Residual Tumor Mass

  2023cites this paper
• Impact of Preoperative Tumor Size on Prognosis of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinomas

  2023cites this paper
• Personalized treatment in localized pancreatic cancer

  2023cites this paper
• Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study)

  2023cites this paper
• Pancreatic adenocarcinoma — current trends in diagnosis and treatment

  2023cites this paper
• Survival Benefit after Shifting from Upfront Surgery to Neoadjuvant Treatment in Borderline Resectable Pancreatic Cancer

  2023cites this paper
• Currently Debated Topics on Surgical Treatment of Pancreatic Ductal Adenocarcinoma: A Narrative Review on Surgical Treatment of Borderline Resectable, Locally Advanced, and Synchronous or Metachronous Oligometastatic Tumor

  2023cites this paper
• Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: current evidence and new perspectives.

  2023cites this paper
• An analysis of time to treatment in patients with pancreatic adenocarcinoma.

  2023cites this paper
• Tissue Resistance Decrease during Irreversible Electroporation of Pancreatic Cancer as a Biomarker for the Adaptive Immune Response and Survival.

  2023cites this paper
• Can 3D visualisation and navigation techniques improve pancreatic surgery? A systematic review

  2023cites this paper
• The diagnostic accuracy of endoscopic ultrasound vs. contrast-enhanced computed tomography in local staging of pancreatic adenocarcinoma: a bi-national multicenter study

  2023cites this paper
• Complications of Percutaneous Irreversible Electroporation for Pancreatic Cancer: A Systematic Review

  2023cites this paper
• Recent Advancements in Electroporation Technologies: From Bench to Clinic

  2022cites this paper
• Innovative Imaging Techniques Used to Evaluate Borderline-Resectable Pancreatic Adenocarcinoma.

  2022cites this paper
• Neoadjuvant therapy in pancreatic neuroendocrine neoplasms: A systematic review and meta-analysis

  2022cites this paper
• Decision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic Adenocarcinoma.

  2022cites this paper
• Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma

  2022cites this paper
• A histopathological study of artery wall involvement in pancreatic cancer surgery

  2022cites this paper
• Impact of margin accentuation with intraoperative irreversible electroporation on local recurrence in resected pancreatic cancer.

  2022cites this paper
• The Role of Inflammatory Markers in Predicting Resectability of Pancreatic Ductal Adenocarcinoma.

  2022cites this paper
• Routine neoadjuvant chemotherapy for all patients with resectable pancreatic ductal adenocarcinoma? A review of the evidence.

  2022cites this paper
• Advances and Remaining Challenges in the Treatment for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

  2022cites this paper
• Adenocarcinoma of the Pancreas

  2022cites this paper
• MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions

  2022cites this paper